Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.175 USD | +2.06% | -1.92% | -0.11% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.11% | 606M | |
+5.16% | 109B | |
+11.49% | 105B | |
+0.15% | 22.25B | |
-12.17% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.79% | 16.85B | |
+4.85% | 13.76B | |
+35.05% | 12.46B |
- Stock Market
- Equities
- ORIC Stock
- News ORIC Pharmaceuticals, Inc.
- ORIC Pharmaceuticals Says Initial Phase 1 Dose Escalation Data for ORIC-533 Shows Evidence of Clinical Antimyeloma Activity